Mounjaro's Sales Skyrocket 502% in India's GLP-1 Market

Mounjaro is on a wild ride, believe it! This amazing medicine from Eli Lilly has become India’s GLP-1 champion, raking in ₹1,256 crore! Sales skyrocketed by 502% as everyone jumps on the injectable train. With a whopping 86% of the market loving injectables, Mounjaro is here to make dreams come true! Let’s embrace this game-changer, friends!